{"entity":{"type":"insider","cik":"0001639637","url":"/insider/0001639637","json_url":"/insider/0001639637.json","name":"Smith Karen L.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":6,"first":"2016-06-15","last":"2024-11-12","span_basis":"filed_date"},"name_variants":[{"name":"Smith Karen L.","source":"filing","n_filings":6,"first_seen":"2016-06-15","last_seen":"2024-11-12"}],"transactions":[{"id":3211643,"accession":"0001600620-24-000114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001600620-24-000114","line_url":"/filing/0001600620-24-000114#line-2","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001639637","owner_name":"Smith Karen L.","owner_display_name":"Smith Karen L.","owner_url":"/insider/0001639637","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5241.0,"shares_display":"5,241","price_per_share":8.43,"price_display":"8.43","price_state":"stated","total_value":44181.63,"total_display":"44,181.63","total_whole":"44,182","shares_owned_after":12672.0,"shares_owned_after_display":"12,672","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-12","scope":"insider"},{"id":5451682,"accession":"0001179110-21-004223","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-21-004223","line_url":"/filing/0001179110-21-004223","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001639637","owner_name":"Smith Karen L.","owner_display_name":"Smith Karen L.","owner_url":"/insider/0001639637","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11864.0,"shares_display":"11,864","price_per_share":140.18510957518544,"price_display":"140.19","price_state":"stated","total_value":1663156.14,"total_display":"1,663,156.14","total_whole":"1,663,156","shares_owned_after":2263.0,"shares_owned_after_display":"2,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-05","scope":"insider","n_lines":2},{"id":5451671,"accession":"0001179110-21-004119","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001179110-21-004119","line_url":"/filing/0001179110-21-004119","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001639637","owner_name":"Smith Karen L.","owner_display_name":"Smith Karen L.","owner_url":"/insider/0001639637","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8925.0,"shares_display":"8,925","price_per_share":136.4708929971989,"price_display":"136.47","price_state":"stated","total_value":1218002.72,"total_display":"1,218,002.72","total_whole":"1,218,003","shares_owned_after":5502.0,"shares_owned_after_display":"5,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-02","scope":"insider","n_lines":4},{"id":2526099,"accession":"0001232524-16-000319","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001232524-16-000319","line_url":"/filing/0001232524-16-000319","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001639637","owner_name":"Smith Karen L.","owner_display_name":"Smith Karen L.","owner_url":"/insider/0001639637","role":"Officer (Global Head of R&D and CMO)","role_mark":"O","role_mark_label":"Officer (Global Head of R&D and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Global Head of R&D and CMO","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":608.0,"shares_display":"608","price_per_share":137.09787450657896,"price_display":"137.10","price_state":"stated","total_value":83355.5077,"total_display":"83,355.51","total_whole":"83,356","shares_owned_after":14181.0,"shares_owned_after_display":"14,181","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-12","filed_date":"2016-08-12","scope":"insider","n_lines":2},{"id":2118347,"accession":"0001639637-16-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001639637-16-000006","line_url":"/filing/0001639637-16-000006#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001639637","owner_name":"Smith Karen L.","owner_display_name":"Smith Karen L.","owner_url":"/insider/0001639637","role":"Officer (Global Head of R&D and CMO)","role_mark":"O","role_mark_label":"Officer (Global Head of R&D and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Global Head of R&D and CMO","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":580.0,"shares_display":"580","price_per_share":143.629,"price_display":"143.63","price_state":"stated","total_value":83304.82,"total_display":"83,304.82","total_whole":"83,305","shares_owned_after":13574.0,"shares_owned_after_display":"13,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-13","filed_date":"2016-07-13","scope":"insider"},{"id":2535209,"accession":"0001639637-16-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001639637-16-000004","line_url":"/filing/0001639637-16-000004#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001639637","owner_name":"Smith Karen L.","owner_display_name":"Smith Karen L.","owner_url":"/insider/0001639637","role":"Officer (Global Head of R&D and CMO)","role_mark":"O","role_mark_label":"Officer (Global Head of R&D and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Global Head of R&D and CMO","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":557.0,"shares_display":"557","price_per_share":149.6142,"price_display":"149.61","price_state":"stated","total_value":83335.1094,"total_display":"83,335.11","total_whole":"83,335","shares_owned_after":12994.0,"shares_owned_after_display":"12,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-13","filed_date":"2016-06-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001600620","name":"Aurinia Pharmaceuticals Inc.","url":"/issuer/0001600620","role":"Director","n_filings":1,"first_seen":"2024-11-12","last_seen":"2024-11-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001280600","name":"ACCELERON PHARMA INC","url":"/issuer/0001280600","role":"Director","n_filings":2,"first_seen":"2021-04-02","last_seen":"2021-04-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001232524","name":"Jazz Pharmaceuticals plc","url":"/issuer/0001232524","role":"Officer (Global Head of R&D and CMO)","n_filings":3,"first_seen":"2016-06-15","last_seen":"2016-08-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001639637","retrieved_at":"2026-08-23T00:47:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}